Becton Dickinson & Co (BDX): Today's Featured Health Care Winner

Becton Dickinson ( BDX) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day up 0.7%. By the end of trading, Becton Dickinson rose $2.00 (2.0%) to $102.01 on average volume. Throughout the day, 1,083,442 shares of Becton Dickinson exchanged hands as compared to its average daily volume of 986,000 shares. The stock ranged in a price between $100.06-$102.06 after having opened the day at $100.39 as compared to the previous trading day's close of $100.01. Other companies within the Health Care sector that increased today were: Rockwell Medical ( RMTI), up 19.5%, Prothena Corporation ( PRTA), up 15.9%, XOMA ( XOMA), up 15.3% and Alnylam Pharmaceuticals ( ALNY), up 15.0%.

Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. Becton Dickinson has a market cap of $19.3 billion and is part of the health services industry. Shares are up 26.7% year to date as of the close of trading on Thursday. Currently there are 4 analysts that rate Becton Dickinson a buy, 4 analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates Becton Dickinson as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front, Mast Therapeutics ( MSTX), down 34.6%, Utah Medical Products ( UTMD), down 13.0%, Synthetic Biologics ( SYN), down 12.3% and Neostem ( NBS), down 7.8% , were all laggards within the health care sector with Jazz Pharmaceuticals ( JAZZ) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Stocks Dive Globally as U.S.-China Trade War Intensifies

Stocks Dive Globally as U.S.-China Trade War Intensifies

Tesla Slumps After McCormack Tweets Husband's Flaming Model-S

Tesla Slumps After McCormack Tweets Husband's Flaming Model-S

China Trade War, Google, JD.com, Tesla, Brooks Koepka - 5 Things You Must Know

China Trade War, Google, JD.com, Tesla, Brooks Koepka - 5 Things You Must Know

Google Invests $550 Million in JD.com and 4 Other Stories to Watch Monday

Google Invests $550 Million in JD.com and 4 Other Stories to Watch Monday

Global Oil Prices Mixed as OPEC Production Talks, China Tariffs Weigh on Markets

Global Oil Prices Mixed as OPEC Production Talks, China Tariffs Weigh on Markets